Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
出版年份 2022 全文链接
标题
Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
作者
关键词
-
出版物
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 36, Issue 1, Pages 31-45
出版商
SAGE Publications
发表日期
2022-01-05
DOI
10.1177/02698811211066709
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
- (2021) Alan K Davis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use
- (2021) Sebastian Hübner et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Predictors of high and low mental well-being and common mental disorders: findings from a Danish population-based study
- (2020) Don Ziggi Ivan Santini et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
- (2020) Albert Garcia-Romeu et al. Frontiers in Psychiatry
- Psychedelic Psychiatry’s Brave New World
- (2020) David Nutt et al. CELL
- Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects
- (2020) Alan K Davis et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term effects of psychedelic drugs: A systematic review
- (2020) Jacob S. Aday et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
- (2020) Theresa M. Carbonaro et al. PSYCHOPHARMACOLOGY
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
- (2020) Kristoffer A. A. Andersen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Cessation and reduction in alcohol consumption and misuse after psychedelic use
- (2019) Albert Garcia-Romeu et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
- (2019) Leor Roseman et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Clinical insight in anorexia nervosa: Associated and predictive factors
- (2019) Philip Gorwood et al. PSYCHIATRY RESEARCH
- Brief Mindfulness Meditation Improves Emotion Processing
- (2019) Ran Wu et al. Frontiers in Neuroscience
- Effects of psilocybin therapy on personality structure
- (2018) D. Erritzoe et al. ACTA PSYCHIATRICA SCANDINAVICA
- Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
- (2018) Tehseen Noorani et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
- (2018) Leor Roseman et al. Frontiers in Pharmacology
- Association Between Insight and Outcome of Psychotherapy: Systematic Review and Meta-Analysis
- (2018) Simone Jennissen et al. AMERICAN JOURNAL OF PSYCHIATRY
- How do psychedelics work?
- (2018) Robin L. Carhart-Harris CURRENT OPINION IN PSYCHIATRY
- Predicting Responses to Psychedelics: A Prospective Study
- (2018) Eline C. H. M. Haijen et al. Frontiers in Pharmacology
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
- (2017) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Studies with psychedelic drugs in human volunteers
- (2017) Edward.M. Sellers et al. NEUROPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
- (2016) Theresa M Carbonaro et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
- (2016) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Socioeconomic gradients and mental health: implications for public health
- (2015) Sarah Stewart-Brown et al. BRITISH JOURNAL OF PSYCHIATRY
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
- (2015) Frederick S Barrett et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Is good insight associated with depression among patients with schizophrenia? Systematic review and meta-analysis
- (2015) Martino Belvederi Murri et al. SCHIZOPHRENIA RESEARCH
- Development of a new measure for assessing insight: Psychometric properties of the insight orientation scale (IOS)
- (2015) Alessio Gori et al. SCHIZOPHRENIA RESEARCH
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- (2014) Peter Gasser et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mindfulness meditation, well-being, and heart rate variability: A preliminary investigation into the impact of intensive Vipassana meditation
- (2013) Jonathan R. Krygier et al. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
- Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
- (2012) Michael P. Bogenschutz et al. Drug Testing and Analysis
- Evaluating the responsiveness of the Warwick Edinburgh Mental Well-Being Scale (WEMWBS): Group and individual level analysis
- (2012) Hendramoorthy Maheswaran et al. Health and Quality of Life Outcomes
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
- (2010) Erich Studerus et al. PLoS One
- Positive Affects and the Transformation of Suffering into Flourishing
- (2009) Diana Fosha Annals of the New York Academy of Sciences
- Obsessive–compulsive disorder with poor insight: A three-year prospective study
- (2009) Francesco Catapano et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now